Insider / CYTOKINETICS INC
Blum Robert I
President & CEO at CYTOKINETICS INC
- Company
- CYTOKINETICS INC
- Ticker
- CYTK
- First filing on record
- October 1, 2025
- Latest trade on record
- October 12, 2026
- SEC filings
- EDGAR ↗
Blum Robert I, President & CEO at CYTOKINETICS INC, has disclosed 52 transactions in CYTK since October 1, 2025: 0 purchases (0 open-market buys) and 25 sales, worth about $21.7M at the reported prices. The latest was filed October 13, 2026, 1 day after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Blum Robert I made no purchases and 23 sales worth $20M, plus 27 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Blum Robert I has traded 1 stock on record; the largest by dollars is CYTK.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 24 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 22 | 262,458 | $18.0M |
| M | Option exercise or conversion | 18 | 247,446 | $1.0M |
| A | Grant or award | 5 | 200,317 | — |
| G | Gift | 4 | 199,202 | — |
| F | Shares withheld for tax | 3 | 39,291 | $2.6M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 39 | 0 | 19 · $17.1M |
| 2025 | 13 | 0 | 6 · $3.5M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CYTK | Option / conversion M | October 12, 2026 | October 13, 2026 | 1d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | October 12, 2026 | October 13, 2026 | 1d | 7,500 | $63 | $472K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 12, 2026 | October 13, 2026 | 1d | 7,500 | $11 | $80K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 28, 2026 | September 28, 2026 | 0d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | September 28, 2026 | September 28, 2026 | 0d | 7,500 | $65 | $491K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 28, 2026 | September 28, 2026 | 0d | 7,500 | $11 | $80K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 14, 2026 | September 15, 2026 | 1d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | September 15, 2026 | September 15, 2026 | 0d | 97,926 | $69 | $6.8M | 10b5-1 planindirect | Form 4 ↗ | |
| CYTK | Other G | September 14, 2026 | September 15, 2026 | 1d | 97,926 | — | — | 10b5-1 planindirect | Form 4 ↗ | |
| CYTK | Other G | September 14, 2026 | September 15, 2026 | 1d | 97,926 | — | — | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Other G | September 14, 2026 | September 15, 2026 | 1d | 1,350 | — | — | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | September 14, 2026 | September 15, 2026 | 1d | 7,500 | $73 | $551K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 14, 2026 | September 15, 2026 | 1d | 7,500 | $11 | $80K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | August 31, 2026 | August 31, 2026 | 0d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | August 31, 2026 | August 31, 2026 | 0d | 7,500 | $70 | $527K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | August 31, 2026 | August 31, 2026 | 0d | 7,500 | $11 | $80K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | August 10, 2026 | August 10, 2026 | 0d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | August 10, 2026 | August 10, 2026 | 0d | 7,500 | $77 | $576K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | August 10, 2026 | August 10, 2026 | 0d | 7,500 | $11 | $80K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 27, 2026 | July 27, 2026 | 0d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | July 27, 2026 | July 27, 2026 | 0d | 7,500 | $81 | $607K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 27, 2026 | July 27, 2026 | 0d | 7,500 | $11 | $80K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 13, 2026 | July 14, 2026 | 1d | 7,490 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | July 13, 2026 | July 14, 2026 | 1d | 7,490 | $82 | $614K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 13, 2026 | July 14, 2026 | 1d | 7,490 | $11 | $79K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | July 13, 2026 | July 14, 2026 | 1d | 10 | $82 | $820 | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | July 1, 2026 | July 2, 2026 | 1d | 7,500 | $85 | $637K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | June 15, 2026 | June 15, 2026 | 0d | 7,500 | $70 | $528K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | May 27, 2026 | May 28, 2026 | 1d | 7,500 | $77 | $579K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | May 14, 2026 | May 14, 2026 | 0d | 7,500 | $78 | $584K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | April 29, 2026 | April 29, 2026 | 0d | 7,500 | $60 | $447K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | April 15, 2026 | April 15, 2026 | 0d | 7,500 | $65 | $490K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | April 1, 2026 | April 1, 2026 | 0d | 7,500 | $67 | $500K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | March 17, 2026 | March 18, 2026 | 1d | 23,928 | $62 | $1.5M | Form 4 ↗ | ||
| CYTK | Sell S | March 17, 2026 | March 18, 2026 | 1d | 12,673 | $62 | $788K | Form 4 ↗ | ||
| CYTK | Other A | March 15, 2026 | March 17, 2026 | 2d | 111,864 | — | — | derivative | Form 4 ↗ | |
| CYTK | Other A | March 15, 2026 | March 17, 2026 | 2d | 1,665 | — | — | derivative | Form 4 ↗ | |
| CYTK | Other A | March 15, 2026 | March 17, 2026 | 2d | 75,258 | — | — | Form 4 ↗ | ||
| CYTK | Sell S | March 9, 2026 | March 10, 2026 | 1d | 7,931 | $61 | $482K | Form 4 ↗ | ||
| CYTK | Sell F | December 22, 2025 | December 29, 2025 | 7d | 2,935 | $63 | $184K | late | Form 4 ↗ | |
| CYTK | Other A | December 22, 2025 | December 29, 2025 | 7d | 5,765 | — | — | late | Form 4 ↗ | |
| CYTK | Other A | December 22, 2025 | December 29, 2025 | 7d | 5,765 | — | — | late | Form 4 ↗ | |
| CYTK | Option / conversion M | December 22, 2025 | December 23, 2025 | 1d | 16,506 | — | — | derivative | Form 4 ↗ | |
| CYTK | Option / conversion M | December 22, 2025 | December 23, 2025 | 1d | 54,727 | — | — | derivative | Form 4 ↗ | |
| CYTK | Option / conversion M | December 22, 2025 | December 23, 2025 | 1d | 16,506 | $7 | $110K | Form 4 ↗ | ||
| CYTK | Sell F | December 22, 2025 | December 23, 2025 | 1d | 30,426 | $68 | $2.1M | Form 4 ↗ | ||
| CYTK | Option / conversion M | December 22, 2025 | December 23, 2025 | 1d | 54,727 | $7 | $365K | Form 4 ↗ | ||
| CYTK | Sell F | December 3, 2025 | December 5, 2025 | 2d | 5,930 | $65 | $386K | Form 4 ↗ | ||
| CYTK | Other G | November 5, 2025 | November 5, 2025 | 0d | 2,000 | — | — | Form 4 ↗ | ||
| CYTK | Sell S | October 30, 2025 | October 30, 2025 | 0d | 5,000 | $63 | $314K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | October 16, 2025 | October 16, 2025 | 0d | 5,000 | $60 | $300K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | October 1, 2025 | October 1, 2025 | 0d | 5,000 | $55 | $275K | 10b5-1 plan | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 13, 2026 | Form 4 | 0001061983-26-000099 | 3 | published | EDGAR ↗ |
| September 28, 2026 | Form 4 | 0001061983-26-000097 | 3 | published | EDGAR ↗ |
| September 15, 2026 | Form 4 | 0001061983-26-000094 | 7 | published | EDGAR ↗ |
| August 31, 2026 | Form 4 | 0001061983-26-000089 | 3 | published | EDGAR ↗ |
| August 10, 2026 | Form 4 | 0001061983-26-000087 | 3 | published | EDGAR ↗ |
| July 27, 2026 | Form 4 | 0001061983-26-000085 | 3 | published | EDGAR ↗ |
| July 14, 2026 | Form 4 | 0001061983-26-000077 | 4 | published | EDGAR ↗ |
| July 2, 2026 | Form 4 | 0001061983-26-000074 | 1 | published | EDGAR ↗ |
| June 15, 2026 | Form 4 | 0001061983-26-000068 | 1 | published | EDGAR ↗ |
| May 28, 2026 | Form 4 | 0001061983-26-000063 | 1 | published | EDGAR ↗ |
| May 14, 2026 | Form 4 | 0001061983-26-000052 | 1 | published | EDGAR ↗ |
| April 29, 2026 | Form 4 | 0001061983-26-000044 | 1 | published | EDGAR ↗ |
| April 15, 2026 | Form 4 | 0001061983-26-000035 | 1 | published | EDGAR ↗ |
| April 1, 2026 | Form 4 | 0001061983-26-000031 | 1 | published | EDGAR ↗ |
| March 18, 2026 | Form 4 | 0001061983-26-000026 | 2 | published | EDGAR ↗ |
| March 17, 2026 | Form 4 | 0001061983-26-000024 | 3 | published | EDGAR ↗ |
| March 10, 2026 | Form 4 | 0001061983-26-000016 | 1 | published | EDGAR ↗ |
| December 29, 2025 | Form 4 | 0001061983-25-000056 | 3 | published | EDGAR ↗ |
| December 23, 2025 | Form 4 | 0001061983-25-000052 | 5 | published | EDGAR ↗ |
| December 5, 2025 | Form 4 | 0001061983-25-000043 | 1 | published | EDGAR ↗ |
| November 5, 2025 | Form 4 | 0001061983-25-000030 | 1 | published | EDGAR ↗ |
| October 30, 2025 | Form 4 | 0001061983-25-000027 | 1 | published | EDGAR ↗ |
| October 16, 2025 | Form 4 | 0001061983-25-000016 | 1 | published | EDGAR ↗ |
| October 1, 2025 | Form 4 | 0001061983-25-000007 | 1 | published | EDGAR ↗ |
Other insiders at CYTOKINETICS INC
- Callos Andrew EVP, Chief Commercial Officer 71 rows
- Malik Fady Ibraham EVP Research & Development 70 rows
- Lee Sung EVP, Chief Financial Officer 38 rows
- Kaye Edward M. MD Director 17 rows
- WIERENGA WENDELL Director 16 rows
- HENDERSON JOHN T Director 13 rows
- Daly James M Director 8 rows
- Harrington Robert Arthur Director 8 rows
- Wysenski Nancy Director 7 rows
- PARSHALL B LYNNE Director 6 rows
Everyone on file, with contracts and lobbying under the company's name: CYTOKINETICS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 24 | 52 | October 1, 2025 | October 13, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.